CD44v5增强IL-4/IL-4Rα/STAT6/SAM68 aix诱导M2极化,并促进三阴性乳腺癌的进展
Zhongjian Ji1, Lan Wang1, Xinyi Bao1
1Department of Clinical Laboratory, The Fourth Hospital of Harbin Medical University, Harbin, China.
Cancer biology & therapy
|November 30, 2025
概括
CD44v5通过增强M2巨分化,促进侵袭性三阴性乳腺癌 (TNBC). 向CD44v5提供了一种新的策略,用于为TNBC治疗重新编程瘤相关巨细胞 (TAMs).
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 具有侵略性,治疗选择有限.
- 瘤相关巨细胞 (TAMs) 是TNBC进展的关键驱动因素.
- 了解TAM重编程机制对于开发新疗法至关重要.
研究的目的:
- 为了研究CD44v5在TAM极化中的作用.
- 探索CD44v5作为TNBC的治疗点.
主要方法:
- 使用单克隆抗体和淘汰细胞系评估CD44v5作用.
- 进行了细胞功能测试 (伤口愈合,入侵,殖民地形成).
- 测量了细胞因子分泌 (IL-4,IL-6) 和巨细胞极化标志物.
主要成果:
- 通过IL-4/IL-4R信号传递,M2巨细胞和TAMs促进TNBC.
- CD44v5封锁抑制了M2极化,并促进了M1转移.
- CD44v5与IL-4Rα结合在一起,防止其内部化.
结论:
- CD44v5通过IL-4Rα/STAT6/IL-4通路促进M2极化,推动TNBC的进展.
- CD44v5是重编程TAM和M2巨细胞的潜在治疗标.
- 向CD44v5为TNBC治疗提供了一种新的策略.
关键词:
在CD44v5中,CD44v5是什么?IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-IL-4-IL-4-IL-4-IL-4-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL is is is is is is is is is what you are is what you are它们的IL-4Rα.瘤的免疫微环境与瘤相关的巨细胞.相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
B Cell Activation and Differentiation
15.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
T Cell Activation and Clonal Selection
14.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.5K


